Objective: To determine whether bacterial pathogens can be detected within the diseased submucosal tissues of patients with Crohn's disease by molecular techniques independent of cultural methods.
C
rohn's disease is a chronic, transmural, granulomatous, idiopathic inflammatory bowel disease of unknown etiology. There is currently no cure and conventional therapy is supportive at best. 1 The natural history of the disease is variable, but the majority of patients tend to have a relapsing and remitting course. 2 The notion that Crohn's disease is an autoimmune disease has long been dismissed. Current concepts focus on a unique combination of genetic predisposition and environmental triggers that result in immunologic dysregulation releasing a cascade of inflammatory mediators that leads to hyperresponsiveness within the gastrointestinal tract. 3 Bacteria and deficiencies in the innate immune response are now thought to play major roles. 3, 4 The predominant etiologic theories include: (1) an abnormally permeable mucosal barrier that results in a continuous translocation of commensal bacteria and/or their antigens into the intestinal wall leading to chronic inflammation, commonly referred to as "leaky gut" 5 ; (2) a loss in the balance between "protective" and "harmful" intestinal bacterial populations leading to a disruption of the intestinal microbiome and chronic inflammation, commonly referred to as "dysbiosis" 6 ; and (3) the existence of an unidentified persistent bacterial pathogen within intestinal tissues, which continuously drives the inflammatory response. 7, 8 However, dysbiosis and leaky gut are common manifestations of gastrointestinal upset [9] [10] [11] [12] and cannot explain "skip lesions" 13 or secondary disease sites such as colonic and esophageal often observed in Crohn's disease. 14 Only the persistent pathogen theory directly addresses causality and possible "triggers."
As conventional methods have failed to consistently identify any specific bacterial species in Crohn's disease that can be attributed to disease causation, 8 we sought to identify bacterial virulence genes and other species-specific genomic sequences independent of cultural methodologies. Because Crohn's disease is characterized by transmural inflammation of the gastrointestinal tract, we hypothesized that bacterial populations within submucosal tissues were more relevant to etiopathogenesis than mucosal biopsies or downstream fecal material used in other studies. 15 Our findings suggest the existence of at least 2 distinct patient populations or biotypes within the Crohn's disease spectrum and the existence of a submucosal microbiome in both health and disease.
MATERIALS AND METHODS

Patient Populations
Full-thickness resected intestinal tissues from patients with Crohn's disease were obtained from the University of Louisville. Similar tissue samples from patients undergoing intestinal surgery for reasons other than inflammatory bowel disease were obtained from the Texas Tech University Health Sciences Center and the University Medical Center and/or the University of Louisville. A total of 14 tissues from patients with Crohn's disease and 6 normal controls were examined. Clinical parameters of the patient populations are presented in Table 1 . Institutional review board approval was obtained from all participating Institutions before the recruitment and enrollment of patients.
Tissue Preparation
Tissues were vortexed in phosphate-buffered saline (PBS) and then washed in fresh PBS for 10 minutes to remove surface contamination. The mucosal layer was then manually excised and approximately 200 mg of the dissected submucosal tissue was vortexed and washed again in PBS for 10 minutes, followed by agitation in 1 mM DLdithiothreitol (DTT) for 15 minutes to dissolve any residual mucus, and another washing in PBS.
After physical and chemical removal of the mucosal tissues, the submucosa was homogenized in 2 mL of water with a tissue homogenizer. 1 mL of the homogenized tissue was transferred to a bead-beating tube and centrifuged at 10,000 g for 2 minutes. DNA was extracted from the sediment as described below. The remaining 1 mL of homogenized tissue was frozen at À801C for future reference.
Mucosal surface DNA was obtained by dissolving the mucous layer physically excised from resected tissues above in 1 mM DTT for 30 minutes and, after removal of the undigested tissue, centrifugation at 10,000 g for 3 minutes. DNA was extracted from the sediment as described below.
DNA Extraction
DNA was extracted from the submucosal tissues based on a modification of the Human Microbiome Project's (HMP) protocol. 16 We found the HMP protocol was ineffective in lysing Mycobacterium paratuberculosis (the official name of this organism is Mycobacterium avium subspecies paratuberculosis, commonly abbreviated as MAP. The authors prefer the original approved name, which more accurately reflects its clinical significance and phenotypic properties) 8 and that the HMP methods failed to yield significant quantities of mycobacterial DNA. As a result, we replaced the garnet beads in the HMP protocol with zirconium, incorporated a 3-minute bead-beating step instead of vortexing, added a manual homogenization step using a tissue homogenizer, and protease K digestion for 20 minutes at 651C before and after bead-beating.
Target Genes and Polymerase Chain Reaction (PCR) Primers
Target organisms and genes were selected based on bacterial agents that have been implicated as causative agents in Crohn's disease in the past 8 or common bacterial causes of chronic diarrhea (Fig. 1) . PCR primers were selected from the literature based on specificity determinations in other studies and the sensitivity/primer-dimer characteristics during optimization as defined below, targeting specific gene sequences (Supplementary Table 1 http://links.lww.com/JCG/A63). For the detection of adherent-invasive Escherichia coli (AIEC), 17, 18 strains NRG 857C (genebank #CP001855.1) and LF82 (genebank #CU651637.1) were compared and the TPR repeatcontaining protein (NRG857_14625) gene (tpR) and glycosyl transferase, family 2 protein (NRG857_10350) gene (glyT) were selected as specific for AIEC.
Optimization of Primers and Template DNA
Primers identified in Supplementary Table 1 (http://links. lww.com/JCG/A63) were tested in various molarity combinations to optimize the concentrations and ratios that produced the lowest C T value, greatest sensitivity, lowest tendency of primer-dimer formation, and consistent T M values from melting curves. To determine the optimal concentration of template DNA from patient submucosal tissues, gradient dilutions of 50, 100, 150, 300, 500 nM, and 1 mM of template DNA per well spiked with 5 genomes of the corresponding bacterial species were tested with the corresponding primer sets and C T and T M values compared.
PCR Assay
Real-time quantitative PCR (qPCR) was performed using the Applied BioSystems Power SYBR-Green Master Mix in an Applied BioSystems Viia-7 Real-Time PCR System using 20 mL total reaction mixture in 384-well plates according to the manufacturer's instructions. All plates were inoculated with an EpMotions 7075 robotic liquid handling system. Data were analyzed using the Applied BioSystems Viia-7 software. All assays were performed in triplicate and included negative controls without patient template DNA (no template controls, NTC), positive controls with 5 bacterial genomes containing the corresponding target gene sequence, and specific primer inhibition controls containing patient template DNA spiked with 10 bacterial genomes containing the corresponding target gene sequence. Each assay required approximately 40 mg of patient DNA.
Verification of Positive qPCR Reactions
All positive qPCR reactions were repeated. Agarose gel electrophoresis was performed on all positive qPCR reactions in 2% agarose. Wells containing DNA bands >75 bp were excised, purified with a gel extraction kit (GenElute; Sigma) and amplicons sequenced in an Applied Biosystems 3130xl Genetic Analyzer according to the manufacturer's instructions and compared with known sequences within the NCBI database. If any of the NTC controls were positive or if all positive controls, including primer-specific inhibition controls, were not all positive, the corresponding primer set was designated a failure and repeated.
qPCR Design and Analysis
The following criteria were used to designate a positive qPCR reaction: (1) the patient template DNA was positive; (2) all negative controls (NTC) were negative; (3) all positive and template spiked controls were positive; (4) the T M value of the positive patient DNA was ± 0.51C of both positive controls; (5) the sample was positive on subsequent qPCR reaction; (6) the amplicon was within 50 bp of the positive controls as determined by gel electrophoresis; and (7) the amplicon sequence was at least 90% homologous with the reference sequence of the gene. qPCR reactions that did not meet these criteria were considered negative.
Quantitation of Target Genes
We used absolute D C T calculations to quantify DNA as follows: D C T /100 ngÂ total DNA extracted in ng/tissue weight in grams = genes/g tissue. Total bacterial counts and quantitation of total bacterial communities within submucosal tissues were determined using universal primers as previously described 19 using E. coli DNA as D C T reference and dividing the total genes/g tissue by 7 (copy number of the 16s rDNA in E. coli) for bacterial genomes/g tissue. Percent bacterial DNA was calculated using the D C T of the universal primers times 5.6 fg (average genome size of E. coli). Percent bacteria of the total bacterial population containing a specific genomic sequence was calculated as above using the D C T value of the specific primer set and assuming a single copy of the gene sequence per genome.
Metagenomic Sequencing
rDNA sequencing was performed as previously described by us. 20 The Q25 sequence data derived from the sequencing process were processed using a proprietary analysis pipeline (http://www.mrdnalab.com). Sequences were depleted of barcodes and primers. Short sequences <150 bp, sequences with ambiguous base calls, and sequences with homopolymer runs exceeding 6 bp were removed. Sequences were then denoized and chimeras removed. Operational taxonomic units were defined after removal of singleton sequences, clustering at 3% divergence (97% similarity). [20] [21] [22] Operational taxonomic units were taxonomically classified using BLAST tool against a curated GreenGenes database 23 and compiled into each taxonomic level into both "counts" and "percentage" files. Count files being the number of sequences and percent being the relative percentage of sequences within each sample.
Statistical Analyses
Data were analyzed using statistical programs inherent within the ViiA-7 analytical software, proprietary analysis software (http://www.mrdnalab.com), Fischer exact test, and/or w 2 test.
RESULTS
Detection of Specific Sequences in Submucosal Tissues
The following genes were not detected within submucosal tissues of any patient group: IS1245 of M. avium complex, UreA and GlyM (UreC) of Helicobacter pylori, mapA, hipO, and glyA of Camplylocater jejuni, IS6110 of Mycobacterium tuberculosis, tcdA and tcdB of Clostridium difficile, ipaH of Shigella spp., and LT1, ST2, Stx1, Stx2, aggR, afaC (daaD), and glyT of the various E. coli strains (data not shown).
Virulence genes and/or species-specific bacterial genome sequences were detected in both Crohn's disease and control submucosal tissues (Table 2) , suggesting the presence of a submucosal microbiome. The M. avium insertion sequence IS1311 was detected in 43% (6/14) of patients with Crohn's disease and 33% (2/6) controls and the M. avium subsp. avium IS901 was detected in 7% (1/14) of Crohn's disease patients and in 17% (1/6) controls. The M. paratuberculosis insertion sequence IS900 was detected in 43% (6/14) patients with Crohn's disease and 17% (1/6) controls, and a unique gene related to lipid metabolism (251F) in M. paratuberculosis was concurrently detected in 43% (6/14) of Crohn's disease patients only. The ttrB gene of Salmonella spp. was also detected in a single patient with Crohn's disease.
Of the E. coli pathogenicity genes, the intimin invasion/adherence gene (eaeA) was detected in 5 of 14 (36%) Crohn's disease patients but not in any controls, the heatstable enterotoxin-1 (st1) from 1 of 14 (7%) Crohn's disease patients and 1 of 6 (17%) controls, and the tpr gene of AIEC from 4 of 14 (29%) patients with Crohn's disease and 2 of 6 controls (33%). In addition to E. coli, invasion/ adherence genes of Salmonella spp. (invA) and of Yersinia spp. (yadA) were detected in 4 of 14 (29%) and in 2 of 14 (14%) Crohn's disease patients respectively, but not in any controls. Multiple adherence/invasion genes were detected in 2 Crohn's disease patients, with both eaeA and invA detected in 2 patients (14%) and eaeA and yadA detected in 1 patient (7%).
Except for a single patient with Crohn's disease (resection due to dysplasia) in which no virulence-associated genes were detected, either bacterial eaeA or invA adherence/invasion genes were detected in 7 of 14 (50%) patients or the IS900 and 251F genes of M. paratuberculosis were detected in 6 of 14 (43%) patients (Table 3 ). There was a significant difference in the detection of invasion/adherence genes, eaeA and invA, (P = 0.01 and 0.008) and IS900/251F genes (P = 0.03 and 0.03) within submucosal tissues as compared with mucosa and nIBD controls, respectively. In no case were M. paratuberculosis-associated genes (IS900/ 251F) found in the same patient in which adherence/invasion genes were found.
Detection of Specific Sequences in Mucosal Surfaces
The total quantity of DNA obtained from digestion of the intestinal mucosal tissues was insufficient for the examination of all target sequences that required a minimum of 40 mg of DNA. As a result, mucosal DNA was examined only from patients that had positive qPCR results from submucosal tissues.
The detection of bacterial genes within mucosal tissues was generally distinct from that detected within submucosal tissues (Table 3) . In most cases, adherence/invasion genes were not detected in mucosal tissues when detected in submucosa of patients with Crohn's disease; in only 1 of 7 submucosal samples from Crohn's disease patients was the eaeA adherence/invasion gene detected within the mucosal DNA extracts. In this single case, the amplicon sequences of the eaeA genes detected within the mucosa were not identical (97% homology) with that detected within submucosal tissues, suggesting different origins. Genes detected within the submucosa of control tissues were equally found within the mucosa (data not shown).
Discordance of Genomic Detection
In almost all cases, there was discordance in the expected detection of specific genomic sequences as related to a specific bacterial species (Table 2) . For example, IS1311 should have been detected in all tissues in which IS900 and IS901 were detected and IS1245 should have been detected concurrently with the detection of IS901. Similarly, the tetrathionate reductase gene (ttrB) of Salmonella spp. should have been detected in all cases in which the Salmonella-specific invasion (invA) gene was detected. In addition to discordance in qPCR gene detection, no bacteria that are known to contain IS900, 251F, eaeA, invA, or yadA genes were identified by 16S metagenomic sequences (Table 4) .
Diversified Submucosal and Mucosal Microbiomes
To further validate the effective separation of mucosal and submucosal bacterial populations, we selected 2 patients with Crohn's disease for metagenomic sequencing of both the submucosal and mucosal microbiome by examination of the bacterial ribosomal DNA (rDNA) genes. One patient was positive for the intimin invasion gene eaeA (CD003) and the other for IS900 and 251F (CD005). Approximately 73% of the rDNA could not be assigned to any specific genus or species; identifiable organisms are shown in Table 4 .
Although the mucosa and submucosa were predominately colonized by organisms of the Phyla Firmicutes and Bacteroides, the relative proportions of these organisms differed between the 2 patients and between mucosa and submucosa in the same patient (Table 4 ). In patient CD003, which contained the intimin eaeA invasion gene, the predominate Phyla in the mucosa were Firmicutes (56%) followed by Bacteroides (29%) and Actinobacteria (15%), whereas in the submucosa, the predominate Phyla were Bacteroides (67%) followed by Actinobacteria (20%), Firmicutes (10%), and Proteobacteria (3%). In patient CD005, which contained the M. paratuberculosis-associated IS900 and 251F genes, the predominate Phyla in the mucosa were Firmicutes (36%) and Bacteroides (38%), followed by Actinobacteria (12%), Verrcomicrobia (7%), and Proteobacteria (4%), whereas in the submucosa, the predominate Phyla were Firmicutes (65%) followed by Actinobacteria (20%), Bacteroides (7%), and Verrucomicrbia (4%).
In addition to differences in the relative amounts of bacterial Phyla between mucosa and submucosal tissues, different species of bacteria were also found within the submucosa that were not present within or on the mucosa and vice versa (Table 4) .
Amplicon Sequencing
The IS900 and 251F qPCR amplicons were 98% homologous with known sequences of M. paratuberculosis in the NCBI database and 99 + % homologous with each other. Minor sequence variations were limited to singlenucleotide variants. The eaeA invasion/adherence genes detected were only 96% homologous with known enteropathogenic E. coli strains based on the NCBI databases. The invA invasion gene, although homologous with each other, only shared 92% identity (similarity) with known Salmonella strains identified in NCBI. On the basis of standard metagenomic classification and assignment criteria, 25 the eaeA and invA genes identified in our studies can only be identified to the unclassified species and unclassified family level, respectively.
Quantitation of Genes Detected and Submucosal Microbiome
The amount of bacterial DNA within submucosal tissues represented only 0.017% of the total DNA extracted. The submucosal tissues from patients with Crohn's disease contained an average of 9.3Â10 4 ± 3.1Â10 2 total bacterial genomes/g of tissue as opposed to an average of 1.2Â10 3 ± 4.3Â10 1 in controls, corroborating increased bacterial translocation. In Crohn's disease patients in which the IS900/F251 genes were detected, assuming a single gene copy of the 251F gene per genome, gene counts averaged 6.2Â10 3 ± 4.1Â10 2 or <2% of the total bacterial population. The eaeA invasion/adhesion gene was detected at a frequency of 5.8Â 10 2 ± 2.2Â 10 2 /g of tissue and represented <0.05% of the total bacterial population count. The invA and yadA invasion genes were detected at a frequency of 3.4Â 10 3 ± 5.1Â 10 2 and 4.9Â10 3 ± 1.3Â10 2 genes/g tissue and accounted for <0.5% of the total bacterial population count, respectively.
Biotypes Correlate With Disease Presentation
The detection of Mycobacterium-associated transposons and plasmid-associated adherence-invasion genes were compared with the clinical disease characteristics at time of surgery (Table 1 ). There was a significant correlation (P = 0.03) between the presence of Mycobacteriumassociation transposons with stricturing Crohn's disease (Table 5 ); IS900/251F was only detected within the submucosal tissues of patients with stricturing disease, whereas invasion/adherence genes were equally distributed within all clinical types.
DISCUSSION
This is the first report to examine the bacterial populations and microbiome of submucosal tissues from surgically resected Crohn's disease tissues as opposed to mucosal biopsies or downstream fecal specimens. Our results suggest that Crohn's disease patients may be divided into distinct populations or biotypes: a population containing plasmid-mediated adherence/invasion genes and the other Mycobacterium-associated IS900 and 251F sequences. These biotypes were found to be mutually exclusive: invasion/adherence genes were not found in patients in which IS900/251F was detected and vice versa. Although these results need to be corroborated with larger patient populations, the data presented herein also provide the first objective evidence that Crohn's disease may not have a single etiology. The ability to subgroup patient populations may have a profound effect on the diagnosis, management, and ultimate cure of the disease.
The discordance of results from both qPCR and metagenomic sequencing, although unexpected, are not inexplicable. The total amount of bacterial DNA within bulk extracted DNA from submucosal tissues amounted to only approximately 0.017% of the total extracted DNA and sequences detected were 0.05% to 2% of the total bacterial DNA. Thus, the specific sequences detected by qPCR represented only 8.5Â 10 À 6 to 3.4Â10
% of the total extracted submucosal DNA. These extremely low levels of target DNA sequences likely account for the competitive inhibition observed in our studies and the discordance of results.
The low copy number of target sequences may also account for the inability to detect mycobacterial rDNA. The bacteria identified by metagenomic sequencing (Table 4) all contain 6 to 7 copies of their 16S rDNA genes. In contrast, M. paratuberculosis contains only a single copy of its rDNA gene (believed to be one of the reasons for its slow growth) thereby reducing sensitivity of metagenomic sequencing 6 to 7 times and increased competitive inhibition. Thus, the IS900/251F sequences likely represent the detection of M. paratuberculosis even in the absence of metagenomic sequence corroboration. Because evidence suggests that IS900 may not be specific for M. paratuberculosis, 8 the detection of IS900 alone was not considered adequate for identification and the detection of both IS900 and 251F was required for classification. The discordance with the invasion/adherence genes eaeA and invA, however, cannot be explained by competitive inhibition alone. The organisms generally associated with these genomic sequences all contain 6 to 7 rDNA copies and, although competitive inhibition is likely at low target concentrations (B10 À 7 % of total DNA), the failure to identify any organism by metagenomic sequencing that are known to contain these plasmids suggests that these virulence genes may exist within yet-to-be-identified species. Discordance of results also supports the suggestion that the eaeA and invA genes detected may represent yet-to-be-identified bacterial populations within the intestinal microbiome.
The human intestinal tract harbors a dense microbial community (>10 12 bacteria/g), which has a profound effect on the host's nutrition, physiology, and immune system. 24 Of the well over 1400 different species of bacteria that may reside within the gastrointestinal tract, 80% of species have never been cultured and are unknown. 26 Much of the microbiome's diversity is thought to be attributed to horizontal gene transfer of plasmids. 27 Although gene transfer is generally rare as a result of colonization resistance in the healthy gut that limits direct contact between prospective donor and recipient organisms, 28 altered enterobacterial colonization densities 29 can boost horizontal gene transfer between pathogenic and commensal bacteria. 30 The specific gene sequences detected by our qPCR methods are either plasmid-mediated or insertion sequences, both of which are known to undergo lateral and recombinant gene transfer. 30, 31 It is likely that the eaeA, invA, and yadA invasion/adherence genes detected within submucosal tissues of patients with Crohn's disease have an ancestral origin in Escherichia, Salmonella, and Yersinia spp., respectively, but do not represent recent events. Although the amplicon sequences of the detected genes were >98% homologous to each other, in all cases, amplicon sequences were only between 92% and 96% homologous with the known sequences of their respective species suggesting distant lateral transfer. Using standard metagenomic classification and assignment criteria, 25 the invasion/adherence genes identified in our studies can only be identified to the unclassified species and unclassified family level, suggesting an unrecognized species. Our inability to correlate the detection of invasion/adhesion pathogenicity genes with metagenomic sequencing of the tissues and the discordance of qPCR results based on the NCBI database further suggests the distant gene transfer of eaeA and invA into commensal bacteria and/or yet-to-beidentified bacterial populations.
The presence of plasmid-mediated invasion/adherence genes could explain high prevalence of phenotypically defined AIEC in certain types of Crohn's disease 17 ; our data suggest that the putative specific gene sequences NRG857_14625 and NRG857_10350 are not specific for AIEC. Likewise, the presence of invasion/adherence genes could explain the value of antibiotic treatment in fistular disease as opposed to stricturing disease manifestations. 32, 33 Our results, if corroborated by larger population studies and development of methodologies applicable to a clinical setting, could revolutionize the diagnosis, management, and treatment of Crohn's disease. It would allow the identification of patient subpopulations and biotypes within the Crohn's disease spectrum and the application of targeted chemotherapeutic treatments that go beyond supportive in nature. 
